Dr. Sonpavde on the Potential for Immunotherapy in Penile Cancer – OncLive
|
Dr. Sonpavde on the Potential for Immunotherapy in Penile Cancer
OncLive Guru Sonpavde, MD, director of Bladder Cancer at the Dana-Farber Cancer Institute, discusses the potential for immunotherapy in penile cancer. There is promise for PD-1 checkpoint inhibitors, as well as CTLA4 plus PD-L1 combination strategies in the … |
